Johnson & Johnson beats first-quarter earnings, revenue estimates
April 16, 2019 at 06:29 AM EDT
Johnson & Johnson reported quarterly earnings and revenue that beat analysts' expectations even as it faces litigation over its talc baby powder and new competition against its prostate cancer drug Zytiga.